skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Leading role of 18F-FDG-PET imaging in early diagnosis of Alzheimer’s disease: an overview

Review

(1578) Views  (259) Full article downloads

Authors: Cason E, Treglia G, Fagioli G

Published Date June 2011 Volume 2011:1 Pages 11 - 19
DOI: http://dx.doi.org/10.2147/RRNM.S16142

Ernesto Cason1, Giorgio Treglia2, Giorgio Fagioli1
1Unit of Nuclear Medicine, Maggiore Hospital of Bologna, Bologna, Italy; 2Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy

Abstract: Early detection of Alzheimer’s disease (AD) is important to reveal preclinical pathological alterations, to monitor disease progression, and to evaluate response to therapy. The study of cerebral glucose metabolism through 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) plays a leading role in early detection of AD because the decrease of cerebral glucose metabolism largely precedes the onset of AD symptoms. This technique demonstrated high sensitivity in early diagnosis of AD, allowing a qualitative and quantitative estimate of cerebral glucose metabolism. Furthermore FDG-PET imaging may help to discriminate the subjects of a high-risk population (like patients with mild cognitive impairment) who more probably will develop AD: an early stage of AD generally shows hypometabolism of medial temporal lobes and parietotemporal posterior cortices; other cerebral cortices are later involved. The combination of FDG-PET with other biomarkers, such as genotype, cerebrospinal fluid markers, and amyloid plaque imaging, may increase the preclinical diagnostic accuracy and offer promising approaches to assess individual prognosis in AD patients.

Keywords: positron emission tomography, dementia, neuroimaging, Alzheimer’s disease, 18F-FDG




 

Other articles by Dr Giorgio Treglia



Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Health literacy and health seeking behavior among older men in a middle-income nation
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Everolimus-eluting stents: update on current clinical studies